A Joint Pharmaceutical Analysis Group (JPAG) and Royal Society of Biology Symposium
Biological activity is a critical quality attribute for biological products. As this class of therapeutics expands and becomes more complex, with the growth of antibody-drug conjugates and cell and gene therapies for example, there are increasing challenges in developing scientifically relevant biological potency assays suitable for each stage of the product life cycle and, in particular, assays that are sufficiently robust for use in the GMP QC environment supporting clinical and commercial manufacturing.
This meeting will consider approaches to overcoming those challenges, including strategies for transitioning assays from R&D into the QC environment, application of new technologies to improve robustness of assays and methods for measuring the potency of cell therapies.
Dr Emma Bowen - Covance
Dr Monica Gunetti - OPBG
Dr Vijay Jethwa - Biologics Consulting
Dr Christiane Niederlaender - Parexel
Dr Ann Yellowlees - Quantics Biostatistics
There will be an opportunity to present posters on the broad subject area of the symposium, subject to acceptance of a submitted abstract. Further details about this are provided on the JPAG webpage
Registration and bookings
Register in advance through the JPAG webpage
. Delegate fees include registration, documentation, lunch and refreshments. If you are a member of the Royal Society of Chemistry (RSC) or the Royal Pharmaceutical Society (RPS), you can join JPAG for free, and benefit from discounted prices. Further details are on the JPAG membership webpage
Concession - £45
Delegate - £100
Student - £45
If you have any questions about the meeting, please contact email@example.com